Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1997 2
1998 1
1999 2
2000 1
2001 1
2002 2
2003 3
2004 6
2005 4
2006 3
2007 2
2008 1
2009 1
2012 2
2015 2
2017 4
2018 2
2019 2
2020 1
2021 2
2022 1
2023 3
2024 3
2025 2
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial.
Mai EK, Bertsch U, Pozek E, Fenk R, Besemer B, Hanoun C, Schroers R, von Metzler I, Hänel M, Mann C, Leypoldt LB, Heilmeier B, Huhn S, Vogel SK, Hundemer M, Scheid C, Blau IW, Luntz S, Weinhold N, Tichy D, Holderried TAW, Trautmann-Grill K, Gezer D, Klaiber-Hakimi M, Müller M, Shumilov E, Knauf W, Michel CS, Geer T, Riesenberg H, Lutz C, Raab MS, Benner A, Hoffmann M, Weisel KC, Salwender HJ, Goldschmidt H; German-Speaking Myeloma Multicenter Group (GMMG) HD7 Investigators; German-speaking Myeloma Multicenter Group (GMMG) HD7. Mai EK, et al. J Clin Oncol. 2025 Apr 10;43(11):1279-1288. doi: 10.1200/JCO-24-02266. Epub 2024 Dec 9. J Clin Oncol. 2025. PMID: 39652594 Free PMC article. Clinical Trial.
Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial.
Harbeck N, Fasching PA, Wuerstlein R, Degenhardt T, Lüftner D, Kates RE, Schumacher J, Räth P, Hoffmann O, Lorenz R, Decker T, Reinisch M, Göhler T, Staib P, Gluz O, Schinköthe T, Schmidt M; AGO-B WSG PreCycle investigators (see Appendix 1). Harbeck N, et al. Ann Oncol. 2023 Aug;34(8):660-669. doi: 10.1016/j.annonc.2023.05.003. Epub 2023 May 16. Ann Oncol. 2023. PMID: 37201751 Free article. Clinical Trial.
Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.
Jin JX, Ginde VR, Huhn S, Reichert P, Bertsch U, Fenk R, Besemer B, Boquoi A, Schroers R, von Metzler I, Hänel M, Mann C, Leypoldt LB, Heilmeier B, Scheid C, Peters-Regehr T, Blau IW, Müller-Tidow C, Luntz S, Holderried TAW, Trautmann-Grill K, Gezer D, Klaiber-Hakimi M, Müller M, Shumilov E, Knauf W, Michel CS, Geer T, Riesenberg H, Lutz C, Raab MS, Weinhold N, Hoffmann M, Benner A, Findeisen P, Weisel KC, Salwender HJ, Mai EK, Goldschmidt H; German-Speaking Myeloma Multicenter Group (GMMG) HD7 Investigators. Jin JX, et al. J Clin Oncol. 2026 Aug;44(22):2079-2086. doi: 10.1200/JCO-25-02957. Epub 2026 May 21. J Clin Oncol. 2026. PMID: 42166704 Free PMC article. Clinical Trial.
Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial.
Gaedcke J, Sahrhage M, Ebeling M, Azizian A, Rühlmann F, Bernhardt M, Grade M, Bechstein WO, Germer CT, Grützmann R, Piso P, Hofheinz RD, Staib L, Beißbarth T, Kosmala R, Fokas E, Rödel C, Ghadimi M; German Rectal Cancer Study Group. Gaedcke J, et al. Sci Rep. 2025 Feb 13;15(1):5401. doi: 10.1038/s41598-024-83105-z. Sci Rep. 2025. PMID: 39948076 Free PMC article. Clinical Trial.
Prediction of the individual risk for the development of brain metastases in patients with non-oncogene-addicted non-small cell lung cancer: Real-world data from the German prospective CRISP registry (AIO-TRK-0315).
Acker F, Wenger K, Reck M, Waller CF, Hoffknecht P, Bethge A, Nusch A, Reiser M, Bernhardt C, Bendel M, Lennartz C, Fleitz A, Jänicke M, Ludwig P, Groth A, Griesinger F, Thomas M, Eberhardt WEE, Sebastian M; CRISP Registry Group. Acker F, et al. Int J Cancer. 2026 Aug 1;159(3):739-749. doi: 10.1002/ijc.70456. Epub 2026 Mar 23. Int J Cancer. 2026. PMID: 41872110
Treatment and outcome in metastatic lobular breast cancer in the prospective German research platform OPAL.
Thill M, Zahn MO, Welt A, Stickeler E, Nusch A, Fietz T, Rauh J, Wetzel N, Kruggel L, Jänicke M, Marschner N, Harbeck N, Wöckel A, Decker T; OPAL study group. Thill M, et al. Among authors: fietz t. Breast Cancer Res Treat. 2023 Apr;198(3):545-553. doi: 10.1007/s10549-023-06882-7. Epub 2023 Feb 18. Breast Cancer Res Treat. 2023. PMID: 36807725 Free PMC article.
Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR.
Geßner C, Fietz T, Losem C, Lück A, Schulz H, Niemeier B, Groschek M, Eschenburg H, Weide R, Kretzschmar A, Frost N, Hipp J, Harde J, Matillon CD, Grebhardt S, Potthoff K. Geßner C, et al. Among authors: fietz t. Curr Med Res Opin. 2022 Dec;38(12):2191-2199. doi: 10.1080/03007995.2022.2113693. Epub 2022 Sep 1. Curr Med Res Opin. 2022. PMID: 36047998 Clinical Trial.
Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.
Rieger K, Loddenkemper C, Maul J, Fietz T, Wolff D, Terpe H, Steiner B, Berg E, Miehlke S, Bornhäuser M, Schneider T, Zeitz M, Stein H, Thiel E, Duchmann R, Uharek L. Rieger K, et al. Among authors: fietz t. Blood. 2006 Feb 15;107(4):1717-23. doi: 10.1182/blood-2005-06-2529. Epub 2005 Nov 8. Blood. 2006. PMID: 16278306 Free article.
CD34 selected alloPBSCT and adoptive immunotherapy.
Knauf W, Fietz T, Schrezenmeier H, Thiel E. Knauf W, et al. Among authors: fietz t. Bone Marrow Transplant. 2000 May;25 Suppl 2:S2-5. doi: 10.1038/sj.bmt.1702342. Bone Marrow Transplant. 2000. PMID: 10933176 Clinical Trial.
51 results